LEP and obesity due to melanocortin 4 receptor deficiency: Therefore, the potential therapeutic strategy for obesity-related OA could be by inhibiting the leptin signal via the reduction of leptin levels and enhancement of SOCS3 expression, or by directly suppressing TLR4 expression.